drugset / Trial / NCT03980704

Preoperative High Protein vs Immunodiet in Surgical Cancer Patients

NCT03980704 ↗

Phase 4 Completed 299 enrolled Stanley Dudrick's Memorial Hospital
RandomizedParallel-groupOpen-labelPrevention

Summary

Immunomodulating nutrition is supposed to reduce the number of complications and the legnth of the hospital stay during the postoperative period in patients after major gastrointestinal surgery. The aim of the study is to assess the clinical effect of immunomodulating oral nutrition in patients undergoing resection for gastrointestinal cancer in the group of well-nourished patients.

Timeline

Start
2019-04-01
Primary completion
2020-12-31
Completion
2021-03-31

Drugs

EvaluationDrugModalityDoseRoute
Subject IMPACT Unknown 400 ml Oral
Comparator resource protein Unknown 400 ml Oral

Indications